Mutations in MECP2 gene are the primary cause of Rett syndrome, a neurodevelopmental disorder that primarily affects girls, and affect 90% to 95% patients with classical Rett syndrome. MECP2 mutations, once thought to be lethal in males, now present a broad spectrum of clinical manifestations in males. This article reports a family with a 9-year-old boy with Rett-like phenotype and congenital blindness, who inherited a novel MECP2 variant (p.P430S) from his asymptomatic mother. The variant was also identified in the asymptomatic maternal grandfather and maternal aunts of the proband, ruling out the possibility that the p.P430S was involved in the phenotype. Findings of the study suggest that a careful evaluation of the pathogenic nature of MECP2 variants identified in males be conducted before proposing genetic counseling or prenatal diagnosis to the family and that the interference of other factors like modifier genes, environment, epigenetics, and mosaicism be taken into account.
Amir RE, Van den Veyver IB, Wan M., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methylCpG-binding protein 2. Nat Genet. 1999 ;23:185-188.
3.
Armstrong J. , Pineda M., Aibar E., et al. Classic Rett syndrome in a boy as a result of somatic mosaicism for a MECP2 mutation. Ann Neurol . 2001;50:692.
4.
Topçu M., Akyerli C., Sayi A., et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet. 2002;10:77-81.
5.
Budden SS, Dorsey HC, Steiner RDClinical profile of a male with Rett syndrome. Brain Dev. 2005;27:S69-S71.
6.
Masuyama T., Matsuo M., Jing JJ, et al. Classic Rett syndrome in a boy with R133C mutation of MECP2 . Brain Dev. 2005;27: 439-442.
7.
Dayer AG, Bottani A., Bouchardy I., et al. MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother. Brain Dev. 2007;29:47-50.
8.
Wan M., Lee SS, Zhang X., et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet. 1999;65:1520-1529.
9.
Imessaoudene B., Bonnefont JP, Royer G., et al. MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet. 2001 ;38:171-174.
10.
Kankirawatana P., Leonard H., Ellaway C., et al. Early progressive encephalopathy in boys and MECP2 mutations. Neurology. 2006; 67:164-166.
11.
Meloni I., Bruttini M., Longo I., et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet. 2000;67:982-985.
12.
Couvert P., Bienvenu T., Aquaviva C., et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 2001; 10:941-946.
13.
Bourdon V., Philippe C., Martin D., et al. MECP2 mutations or polymorphisms in mentally retarded boys: diagnostic implications. Mol Diagn. 2003;7:3-7.
14.
Van Esch H. , Bauters M., Ignatius J., et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet. 2005;77:442-453.
15.
Erlandson A. , Samuelsson L., Hagberg B., et al. Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in MECP2 gene of Swedish Rett syndrome patients. Genet Test. 2003;7:329-332.
16.
Ariani F., Mari F., Pescucci C., et al. Real-time quantitative PCR as a routine method for screening large rearrangements in Rett Syndrome: report of one case of MECP2 deletion and one case of MECP2 duplication. Hum Mutat. 2004;24:172-177.
17.
Smeets E., Terhal P., Casaer P., et al. Rett syndrome in females with CTS hot spot deletions: a disorder profile. Am J Med Genet A. 2005;132A:117-120.
18.
Archer HL, Whatley SD, Evans JC, et al. Gross rearrangements of MECP2 gene are found in both classical and atypical Rett syndrome. J Med Genet. 2006 ;43:451-456.
19.
Meins M., Lehmann J., Gerresheim F., et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J Med Genet. 2005;42:e12.
20.
Del Gaudio D., Fang P., Scaglia F., et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med. 2006;8:784-792.
21.
Hardwick SA , Reuter K., Williamson SL, et al. Delineation of large deletions of the MECP2 gene in Rett syndrome patients, including a familial case with a male proband. Eur J Hum Genet. 2007;15:1218-1229.
22.
Villard L.MECP2 mutations in males. J Med Genet. 2007 ;44: 417-423.
23.
Hagberg B., Hanefeld F., Percy A., et al. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatrics Neurology Society Meeting, Baden, Germany, 11 September 2001. Eur J Paediatr Neurol. 2002;6:293-297.
24.
Christodoulou J., Grimm A., Maher T., et al. RettBASE: The IRSA MECP2 Variation database-a new mutation database in evolution. Hum Mutat. 2003;21:466-472.
25.
Ramensky V. , Bork P., Sunyaev S.Human non-synonymous SNPs: server and survey . Nucleic Acids Res. 2002;30:3894-3900.
26.
Ng PC, Henikoff S.SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;13:3812-3814.
27.
Renieri A., Meloni I., Longo I., et al. Rett syndrome: the complex nature of a monogenic disease. J Mol Med. 2003;81:346-354.
28.
Ishii T., Makita Y., Ogawa A., et al. The role of different X inactivation pattern on the variable clinical phenotype with Rett syndrome. Brain Dev. 2001;23:S161-S164.
29.
Huppke P., Maier EM, Warnke A., et al. Very mild cases of Rett syndrome with skewed X inactivation . J Med Genet. 2006;43: 814-816.
30.
Takahashi S. , Ohinata J., Makita Y., et al. Skewed X chromosome inactivation failed to explain the normal phenotype of a carrier female with MECP2 mutation resulting in Rett syndrome. Clin Genet. 2008;73:257-261.
31.
Clayton-Smith J., Watson P., Ramsden S., et al. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet. 2000;356:830-832.
32.
Schanen C.Rethinking the fate of males with mutations in the gene that causes Rett syndrome . Brain Dev. 2001;23:S144-146.
33.
Laccone F., Zoll B., Huppke P., et al. MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution. J Med Genet. 2002;39:586-588.
34.
Moncla A., Kpebe A., Missirian C., et al. Polymorphisms in the C-terminal domain of MECP2 in mentally handicapped boys: implications for genetic counselling. Eur J Hum Genet. 2002; 10:86-89.
35.
Ravn K., Nielsen JB, Uldall P., et al. No correlation between phenotype and genotype in boys with a truncating MECP2 mutation. Med Genet. 2003 ;40:e5.
36.
Santos M., Temudo T., Kay T., et al. Mutations in the MECP2 gene are not a major cause of Rett syndrome-like or related neurodevelopmental phenotype in male patients. J Child Neurol. 2009;24: 49-55.
